Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I have bought and used the product, and my mother used it. Great is an understatement, so I agree why cannot get a major launch and super cash flow. Crazy ???
I feel like this stock is coiled for an explosion with the right news. If only the company had a leader that could produce more than fluffy words. I wonder what Otiko's reputation in the medical community really is. The product exists and reportedly is the greatest thing since sliced bread. Then why can't a deal be struck to market and sell it. Why is that so difficult? You cry wolf too many times and eventually nobody believes you.
I imagine this has been posted before but I did verify his medical license:
OTIKO, CHRISTOPHER A.
LICENSE NUMBER: 4159 LICENSE TYPE: DOCTOR OF PODIATRIC MEDICINE
LICENSE STATUS: LICENSE RENEWED & CURRENT hint EXPIRATION DATE: NOVEMBER 30, 2025
SECONDARY STATUS: N/A
CITY: TARZANASTATE: CALIFORNIACOUNTY: LOS ANGELESZIP: 91356
Off topic, Myrtle Beach is warm. 92 feelie like 102 and hotter tomorrow. I know not the hottest raw temp, but we sure pack the humidity on top. Thank goodness for modern AC. Poor older generations.
It seems things are getting really bad in ViaDerma. Looks like shareholders in here are getting irate as well. Just business folks, good business. CEO doesn’t take this personal, they just see dumb and easy money, why not milk it? I strongly recommend to cool down a bit and let this to go back up again. Enjoy the 4th folks!!! Not worth the suffering over the Nigerian Vampire
IMO it's coming soon. Agreed that Otiko needs to step down and terminate his ridiculous stock awards and compensation on his own in lieu of litigation which would likely cost him well over $100,000 just to fight it. He has done nothing in years to benefit the company or its shareholders. Always false PRs and a ton of dilution to follow.
Through some thorough public records and social media research it looks like Otiko now lives in Coronado, CA in a multi million dollar house a block from the beach and likes to fly on fly private jets for vacations around the world. Based on other responses on the boards, it looks like he may have been fired from Wound Pros too. If that's the case, they must have figured out he's a fraud and cut ties fast. Of course this is speculation, but without any actual answers from the useless PR guy, who should be fired immediately, or the company, that's all anyone here is left with today.
Still no word on the march vitastem deliveries overseas. Nothing about Nupelo in over a year. No new state licensing deals. No VA contract. No HMO contract. No OTC uplisting. No US distribution deals. No social media updates in over 4 months. No meaningful PRs. Nothing.
No inventory either! https://getvitastem.com/products/topical-antibiotic "Product is out of stock and orders are not being accepted until stock is replenished"
Last tweet on 2/1:
"$VDRM Update: The company has received licensing payments totaling $1.2M and will be updated into our financials accordingly. More updates to follow."$VDRM Update: The company has received licensing payments totaling $1.2M and will be updated into our financials accordingly. More updates to follow.
— ViaDerma (@viaderma) February 1, 2024
Time and money might be better spent calling a shareholder meeting and firing him. Shareholders could then approve a slate of reputable directors and appoint someone else to run the company. Other agenda items would be to terminate that ridiculous stock award and terminate all licensing arrangements with any Otiko affiliated entities. Of course with these actions, the company will end up in litigation anyway.
Looks like a major lawsuit by shareholders will be needed to get actual answers.
Good grief....which is it 🤡.....
You said before ALL your posts were facts. 😂 😢
That's my opinion No one ask you to agree
That's my opinion No one ask you to agree
Let me spell it out for you. Your predictions of news mean nothing.
Now tell us something we didn't already know
It goes without saying but I'll say it anyway. Everything said on this board, every prognostication, guess, prediction, estimate, etc. is purely opinion and speculation and must be taken with a huge grain of salt. No one knows anything on this board otherwise it would be inside information. Otiko is accountable to no one and moves at his own glacially slow speed notwithstanding any statements to the contrary.
Off to another terrible start of the second half of the year. Nvda trades 40 million already and here we are at 2226. SADNESSES.
Sloppy, I told you I would update folks on the Vitastem Ultra Jumbo Suppositories when the Doc let me know. Production had to be delayed because of the size issue of them falling out and a slight issue with the packaging. I am not one to predict news on their availability until I actually hear from the Doc. I know you and DB are very anxious but good things come to those who wait. Sit tight....well you know what I mean. LMMFAO
Sad to say and hate to admit that you are right. 😀 but we are due for a run. Hopefully the Dr. runs out of money and throws us a bone $$$$$$$$ and my 2.5 mil are out of here $$$$$
No quarrels there, that’s why I’m here as well. I’ve been playing VRDM for years and can always count on the multibagger runs. Everything in between is just a waste of time.
Wait for volume to dry out then you see the pop. When? Who knows but it’s coming and soon.
You are consuming again. I thought you did quit
Yes indeed. We do need an expansion in monthly states added and some country signed, check in the bank contract.
Let’s be real, most everyone here knows this is a POS stock. All of these PR’s are worthless. This will run and run hard when the MM’s are ready to let it run. When it does we are likely to see 1000-2000%.
That’s the real reason most people are here. The bashers wants to get in as low as possible and wait for the Big run. No one here is expecting this to rise to Nasdaq, just get there multi baggers and leave.
If you’ve been following this stock you will see the big runs that comes with VDRM. When it’s ready you will be happy, until then you’re wasting your time on this thread. It’s for people who are bored and looking for the entertainment of waiting on a multibagger run. That’s why I’m here today.
If those 10Q are not accurate, this will send the PPS back to stone age. Double digits is a dream where we at now compare to what is coming. If they do not fix this well and in-the-quick, TRIPS is expected... 0.0005
Just a deflection......
More or less ignored the questions.....
After 5 flabbergasting weeks, a "response" was FINALLY received from IR (Rich), regarding conflicting official REVENUE information, for more than a year, between official 10Q's and official press releases. Response was "You need to wait for news release", with, of course, no mention that it is coming near-term. Add infuriating, but typical, no sense of urgency to fulfill obligation to provide timely, CURRENT and CORRECT information to shareholders and public, and regulators (if 10Qs have been in error for last 5 quarters) to growing list of valid complaints. At the rate things barely move, if at all, I wonder if long overdue corrections will be made and incorporated, with issue of 2Q24 10Q circa August 15th?
At this rate, the stock will be headed to trips if not zero. IR guy is totally useless and Otiko is probably hiding out somewhere in Nigeria. The SEC lawsuits cannot come soon enough. Still not one mention about shipping vitastem overseas, Nupelo updates, Dubai deal, VA or HMO deals, or anything actually going on there. Otiko needs to step down and bring in someone competent to run the show immediately.
My Truth and Facts make you jealous WHY?
no no no, he is a dancer, I get it but he is our dancer. Complaints will bury us along with such. Let's wait it out, I am frustrated as well but we gotta take this business as usual. No personal feelings on this, we are PRO... The Doc is doing his moves and we gotta navigate with such as well. I think we are going to be fine, too much at play, the Doc just need time for the next round
This board is disgusted every time 🤡 posts. 😂
That would get his attention faster than anything… Just not sure if what he does outside of the medical profession matters. Maybe it does though. Thoughts?
He’s done his research on HOW TO “legally” scam people via fake penny stock companies. I’m sure he’s protected himself.
Could someone report him to the medical board in CA? Unethical activity (outside of medical profession)?
Would take about 5mins of reading PRs and FINs to see he has misled and flat out lied to people for years now…
Or it’s taken as a “loan” lol.
Sales mean nothing. Biogenix collects the $$$. End of story
You have strong points, I agree and won’t debate such BUT, remember, every of those BS the Doc came up with were powerful enough to spike the PPS to at least $0.03… Also, it is not strange OTCM to be full of BS like this YET people make money out of. I suggest to keep normal, wait for the Doc next sell speech, hype it all the way and KABOOM: GTFO Run bitches, run as fast as you can and take your money back. That’s my plan now 😂
Let's get real here. How long has Ultra been available? How many times have we heard of overseas shipments ready to go? The latest shipment was announced to take place at the end of March. Nothing. What happened to Nupelo? Fancy packaging in the picture along with a website then.... nothing. Even Sloopy posted he heard it would grow hair on a cue ball. Right. Could go on and on and how about the online price increase for Ultra up to $149.95. What is that about? Please spare all of us with the BS as most of us longs are immune to it. Hoping the Doc comes out with at least one more BS PR to prompt a run so many of us can get out of this POS. And the ironic part is Ultra is a proven product. Makes no sense.
My main point of view: hope!!! Unfortunately it is the ultimate goal in here. It sounds innocent but if his ambitions are big, he could do a few moves for his own sake and the company that may drive the PPS well. Those all accusations are allegations that probably are misunderstand and can be clarified if he deemed so. It is another weak, but possible angle to consider. Time will tell but I am telling you, the SEC path will kill any chances of us getting our money back if he is natty. Ask the QNTA shareholders. CEO got a $150K fine and delisted BUT his company still operating as normal in the private sector AND SHAREHOLDERS, got the tax write off
Yes that is a big plus.
At least no one is selling.
I don’t think anyone has done such. The questions to ask are, does it matter? Do you believe the Doc to be soo naïve for him not to be aware of his actions? He knows exactly what he is doing, there is not mistakes in this. Do you really think he will confess to a stranger he doesn’t have any sympathy to of any wrongdoing? He will fill you of candy 🍭 until you get satisfied and if you don’t fall for his sweets, he will not continue with the interaction because he will see you as a threat. Probably block your number if you break the glass. Human behavior
Pretty sad not even enough to get any buyers interested in a trade almost 10:45 ,,,,"0" trades
Has anyone complained directly to Otiko with these types of allegations? I my mind, that would be the first step. To Otiko: Attached please find a copy of a compliant that the shareholders intend to file with the SEC. Some thoughts for a complaint:
"On such and such occasions from the period from June 2023 through June 2024, I and many other shareholders have reached out to Dr. Otiko requesting information on the status of various public news announcements. Otiko has consistently refused or otherwise failed to provide any meaningful updates on any announced deals. In fact from 2017 through 2024, there have been "X" number of announcements covering various topics as summarized below.... As of the date of this letter, not one such annoucement has ever come to fruition. In addition, Otiko has consistently failed to update the notes to the financial statements for over 7 years. Much of the information stated therein is stale and outdated and provides no meaningful information on the status of any prior announcements or present business activity. Furthermore, Otiko has never held a shareholder meeting and communications with the shareholders, when published, are vague, intentionally couched to become difficult or impossible to verify and provide no real basis in fact.
I note that the during such period of time, Otiko has diluted ishares outstanding from _____________ to _____________ and increased his cash compensation to $___________.
In addition, Otiko has awarded himself stock compensation as follows: .....
Furthermore, Otiko has usurped corporate opportunity by transferring distribution rights to the company's flagship product to a private entity owned by Otiko and has carved out lucrative licensing arrangements for his privately held company. Such licensing arrangement permits Otiko to sell the product under another trade name and retain a significant source of revenue from such sales. In doing so, Otiko has bifurcated and stripped a valuable asset from the company for his own personal benefit."
Multiple SEC complaints and shareholder lawsuits will change that very quickly. There are numerous other OTC tickers who have and are currently under investigations. If they are frauding investors, they will get charged. They PR BS, dilute, and repeat. No sales seem to have been made overseas or any products shipped like they told shareholders it would be done in March. Nothing about Nupelo or Dubai or all the 50 states licensing deals which were supposed to be done by the end of last year. They cannot hide behind their BS or from angry shareholders any longer.
You got sooo much faith on the SEC. They are so busy dealing with their own things that won’t have time for small time punk like this ticker. Unless of course, O comes out on the radar. He has been keeping a low profile, hard to follow up with
It's borderline criminal if not outright fraud. I'm sure a thorough SEC investigation will uncover everything. Time will tell but if the next PR is absolute BS again and all the persistent shareholder questions are not answered soon, then all hell will break loose on management. It's far past due for some real answers.
Followers
|
619
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
74600
|
Created
|
10/27/08
|
Type
|
Free
|
Moderators |
ViaDerma's proprietary transdermal delivery system allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy.
The technology allows transfer of chemicals through the stratum corneum (outer layer of skin) with a diffusion constant which is 10,000 times higher than the diffusion constant which characterizes water movement through the stratum corneum.
This enables ViaDerma to pair almost any active ingredient with the technology and provide rapid transport of the medicine right to the site of action.
The first product is a broad spectrum tetracycline-based topical antibiotic is the only antibiotic in the world that kills bacteria both a physical and a chemical mechanism. All known antibiotics (other than ours) primarily use only a chemical mechanism of kill. The physical mechanism of kill is a key feature of what we call Rapid Active Ingredient Delivery System (RAIDS). One result of RAIDS is that tetracycline is carried in higher concentrations, more quickly, to and through the cell walls, where the tetracycline can become more effective than if conventional antibiotics were used. Conventional antibiotics require more time (usually prescribed for 5 to 7 days for best results), whereas our tetracycline-based products usually produce desirable results in 24 hours (or less) because of the RAIDS effect.
A second important result of RAIDS is that the topical antibiotic kills all harmful Gram positive and Gram negative bacteria that have been available for testing. We believe this is the world’s strongest broad-spectrum topical antibiotic available.
The potential commercial impact is immense. Drug developers believe it takes much longer for bacteria to develop drug resistance to a physical kill mechanism. This is because it is relatively easy for bacteria to change their response to a chemical threat, but it takes numerous generations for bacteria to grow a new kind of cell wall structure to respond to a physical threat.
Our novel approach to overcome drug resistance of antibiotics is designed to sustain the effectiveness of antibiotics and other topical drugs for many years. This gives new topical drug products a longer useful lifetime and therefore more commercial value. This technology, when licensed to larger pharmaceutical companies, may provide stronger incentive for the discovery and development of new antimicrobial drugs. In recent years, the dearth of new antibiotics has been largely due to the uncertain new-drug commercial lifetime which is diminished when bacteria develop immunity to that drug.
In addition the technology can be licensed to other companies to convert existing oral drugs to transdermal medications extending the profitably of the existing drug.
We are developing products in the following fields of use;
Treats all types of bacteria including MRSA, VRE and other flesh eating bacteria. Fights drug resistant bacteria. $6B/year global market.
Onychomycosis, a fungal infection of the toenails, is a major health problem. It is estimated that there are in excess of 40 million sufferers with this condition in the USA. It is a problem throughout the world. A recent European study showed that the prevalence of Onychomycosis may be as high as 26.9%. Fungal resistance can occur when the oral antifungal agents are used on a long-term basis. Topically applied antifungal drugs may work somewhat better adjunctive to surgical removal or chemical dissolution of the nail plate. Yet, this often ineffective and traumatic procedure leaves the subject without a nail for months at risk for re-infection. Given the limitations of current treatment options in this $3B market, there is a great need for a simple, nontoxic and effective alternative treatment. Estimated Global prevalence rate: 140 million.
Treats symptoms of Influenza which is a$4B/ year global market: Common
Diabetic foot wounds.
Per 3/8/18 PR: ViaDerma’s technology is currently being used in Elixr Cannabis products; Topical Balm, Topical Serum and Topical Spray. Sales have begun in Canada.
Per 12/7/17 PR: The Company has signed an MOU and will start production of its Patent Pending CBD or Cannabinoids product line. The Company would combine its two Patent pending technologies, the MMJ Patent #62466209, a patent for delivering medical marijuana / cannabis to the body by applying the medication onto the skin in an ointment base topical solution and the second Provisional patent # 62433964 for enhanced antibiotic and drug delivery for "Aqueous Topical Applications" for human and veterinary uses. The Company would combine its proprietary solutions with CBD's and other natural products that treat psoriasis, fibromyalgia for pain and other ailments.
Per 1/23/18 PR: The Company has also a licensing and distribution agreement in place with its Canadian partners to produce a CBD Topical Serum, which has a 92% absorption rate powered by ViaDerma's Patent Pending Dual Carrier Technology. The CBD and Terpene profile (enriched with specific essential oils and vitamins C, and D) is crafted to alleviate Chronic Dry Skin, Psoriasis, Eczema, Rosacea, and many other skin conditions. The serum has anti-inflammatory, anti-bacterial, and chronic pain relief properties that are absorbed by the skin and provide overall healing benefits. Sales are expected to begin in the first quarter of 2018 and are projected to generate approximately $2 million annual revenues.
The Patented Pending CBD or Cannabinoids product line. The Company would combine its two Patent pending technologies, the MMJ Patent, a patent for delivering medical marijuana / cannabis to the body by applying the medication onto the skin in an ointment base topical solution and the second Provisional patent for enhanced antibiotic and drug delivery for "Aqueous Topical Applications" for human and veterinarian uses. The Company would combine its proprietary solutions with CBD's and other natural products that treat psoriasis, fibromyalgia for pain and other ailments. The Company plans to continue to expand its (IP) "Intellectual Property Portfolio" in 2018.
CBD is a compound found in the Cannabis family of plants such as hemp. CBD is combined into our topical body care products like Elixr's Topical Balm, Serum, and Spray.
CBD is an antioxidant. Antioxidants protect our skin from damaging exposure to smoke, UV rays, and environmental pollutants. Cannabinoid receptors are located all throughout the skin, Topical CBD products interact with those receptors resulting homeostasis and healing. Studies show that CBD can help treat an array of skin conditions such as eczema, psoriasis, rosacea, and acne.
"What is Intellectual Property?" - A Publication by the World Intellectual Property Organization -
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |